Owlet Baby Care, Inc.
12
3
3
8
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
0.0%
0 terminated/withdrawn out of 12 trials
100.0%
+13.5% vs industry average
0%
0 trials in Phase 3/4
25%
2 of 8 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (12)
Accuracy Evaluation of the Owlet OSS 3.0-M1 Sensor in Toddlers and Preschoolers
Role: lead
Remote Oximeter Monitoring Post-discharge to Reduce Emergency Room Visits and Rehospitalization
Role: collaborator
Testing a Wearable Monitor for Fetal Heart Rate Estimation, Fetal Movement and Uterine Activity Detection
Role: lead
Evaluation of Accuracy of the Owlet OSS 3.0 Sensor in the Neonatal Population
Role: lead
Accuracy Of The Owlet OSS 3.0 During Standardized Stable Hypoxia Plateaus
Role: lead
Bradycardia Recognition and Detection in Young Infants Part-I
Role: collaborator
Owlet Smart Sock 3 Accuracy on Infants
Role: lead
Accuracy of BabySat V3 With Profound Hypoxia and Motion
Role: lead
An Observational Study of Skin Reaction in Infants Using the Owlet Sock OSS 3.0
Role: lead
Accuracy of Owlet Smart Sock Sensor 3rd Generation With Profound Hypoxia
Role: lead
Owlet Band Observational Study: Observe the Use of a New Pregnancy Tracker for Expecting Mothers
Role: lead
SpO2 Accuracy Comparison of Smart Sock V. 2 SpO2 to Arterial Blood CO-Oximetry
Role: lead
All 12 trials loaded